Suchergebnisse - "Larock, Anne-Sophie"

PubPharm (21)

1

Clinical risk assessment of modelled situations in a pharmaceutical decision support system : a modified e-Delphi exploratory study

enthalten in: International journal of clinical pharmacy | 2024

von Bouet, J. | Potier, A. | Michel, B. | +5

2

The Impact of Strong Inducers on Direct Oral Anticoagulant Levels

enthalten in: The American journal of medicine | 2021

von Sennesael, A. | Larock, A. | Hainaut, P. | +5

3

Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application

enthalten in: Journal of thrombosis and haemostasis : JTH | 2019

von Douxfils, J. | Morimont, L. | Bouvy, C. | +10

4

Assessment of the analytical performances and sample stability on ST Genesia system using the STG‐DrugScreen application

enthalten in: Journal of Thrombosis and Haemostasis | 2019

von Douxfils, J. | Morimont, L. | Bouvy, C. | +10

5

Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study

enthalten in: Thrombosis journal | 2018

von Sennesael, A. | Larock, A. | Douxfils, J. | +7

6

Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study

enthalten in: Thrombosis journal | 2018

von Sennesael, A. | Larock, A. | Douxfils, J. | +7

7

Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants : a prospective study

enthalten in: British journal of clinical pharmacology | 2018

von Sennesael, A. | Larock, A. | Devalet, B. | +6

8

Rivaroxaban plasma levels in patients admitted for bleeding events : insights from a prospective study

enthalten in: Thrombosis journal | 2018

von Sennesael, A. | Larock, A. | Douxfils, J. | +7

9

Estimation of Rivaroxaban Plasma Concentrations in the Perioperative Setting in Patients With or Without Heparin Bridging

enthalten in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis | 2018

von Lessire, S. | Douxfils, J. | Pochet, L. | +6

10

Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures

enthalten in: Expert opinion on biological therapy | 2017

von Vornicu, O. | Larock, A. | Dincq, A. | +4